The point of view of the patient with prostate cancer is approached here in two ways; firstly through the comments of a psychologist on the history of a patient with prostate cancer and the dialogue with an experienced urologist. The treatment should not only be understood, but also accepted ...
Prostate cancer, particularly advanced prostate cancer, should be considered as a chronic disease that requires multidisciplinary management. Each health professional involved the urologist of course, but also the other therapists, especially the general practitioner and nurse, should place their activities...
Comment détecter le cancer de la prostate ? Choisissez un calendrier en ligne adapté à vos besoins Comment faire pour vendre votre maison à sa juste valeur ? Tendances enfants printemps-été 2020 Occupez-vous pour rester en bonne santé Catégories Actualités Auto/Moto Autres Finance...
Ces lésions ressemblent parfois à un CaP de faible grade de Gleason (GG). La connaissance de ces aspects et l’immuno-histochimie permettent d’amener le pathologiste vers le bon diagnostic. Summary The diagnosis of prostate cancer (PCa), especially limited adenocarcinoma on needle biopsy, ...
Unissons-nous pour s’attaquer à la santé mentale, la prévention du suicide et les cancers de la prostate et des testicules.
EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРусскийTürkçeאנגלית 9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook ...
Erika Naakka : Présentation de matrices et de tests in vitro plus fiables pour la recherche sur le cancer Instituts Haartman,Helsinki 8.8 miles d'Espoo AtelierMédical et pharmaceutique Fri, 22 Mar 2024 Minna Mutka : Les cellules immunitaires dans le microenvironnement tumoral du carcinome du ...
Numerous lesions of the prostate, such as atrophy, adenomatous atypical hyperplasia (adenosis) or PIN can be misdiagnosed with prostatic cancer, and confused with ASAP, leading to perform additional biopsies. In such lesions, the pathologist can perform an immunohistochemical study with the anti-high...
The management of metastatic castration-resistant prostate cancer markedly changes over years. The Profound and Propel studies have proven olaparib is effective in this disease. It is now possible to prescribe this drug for specific indications and conditions: as monotherapy inBRCAmutated patients who ...
Jusqu'a present la mitoxantrone representait le traitement de reference du cancer de prostate hormonoresistant (CPHR). Le docetaxel a montre son efficacite... J. Ferrero - 《Bulletin Du Cancer》 被引量: 0发表: 2005年 Quelles nouvelles stratégies dans le traitement du cancer colorectal métast...